Cargando…

Development of immunodetection system for botulinum neurotoxin serotype E

BACKGROUND & OBJECTIVES: Botulism, a potentially fatal paralytic illness, is caused by the botulinum neurotoxins (BoNTs) secreted by Clostridium botulinum. It is an obligate anaerobic, Gram-positive, spore-forming bacterium. BoNTs are classified into seven serotypes based on the serological prop...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarita, R., Ponmariappan, Sarkaraisamy, Sharma, Arti, Kamboj, Dev Vrat, Jain, A. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118135/
https://www.ncbi.nlm.nih.gov/pubmed/30168493
http://dx.doi.org/10.4103/ijmr.IJMR_1375_16
_version_ 1783351869216653312
author Sarita, R.
Ponmariappan, Sarkaraisamy
Sharma, Arti
Kamboj, Dev Vrat
Jain, A. K.
author_facet Sarita, R.
Ponmariappan, Sarkaraisamy
Sharma, Arti
Kamboj, Dev Vrat
Jain, A. K.
author_sort Sarita, R.
collection PubMed
description BACKGROUND & OBJECTIVES: Botulism, a potentially fatal paralytic illness, is caused by the botulinum neurotoxins (BoNTs) secreted by Clostridium botulinum. It is an obligate anaerobic, Gram-positive, spore-forming bacterium. BoNTs are classified into seven serotypes based on the serological properties. Among these seven serotypes, A, B, E and, rarely, F are responsible for human botulism. The present study was undertaken to develop an enzyme-linked immunosorbent assay (ELISA)-based detection system for the detection of BoNT/E. METHODS: The synthetic gene coding the light chain of BoNT serotype E (BoNT/E LC) was constructed using the polymerase chain reaction primer overlapping method, cloned into pQE30UA vector and then transformed into Escherichia coli M15 host cells. Recombinant protein expression was optimized using different concentrations of isopropyl-β-D-1-thiogalactopyranoside (IPTG), different temperature and the rBoNT/E LC protein was purified in native conditions using affinity column chromatography. The purified recombinant protein was checked by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and further confirmed by western blot and matrix-assisted laser desorption ionization-tandem time-of-flight (MALDI-TOF). Polyclonal antibodies were generated against rBoNT/E LC using Freund's adjuvant in BALB/c mice and rabbit. Sandwich ELISA was optimized for the detection of rBoNT/E LC and native crude BoNT/E, and food matrix interference was tested. The developed antibodies were further evaluated for their specificity/cross-reactivity with BoNT serotypes and other bacterial toxins. RESULTS: BoNT/E LC was successfully cloned, and the maximum expression was achieved in 16 h of post-induction using 0.5 mM IPTG concentration at 25°C. Polyclonal antibodies were generated in BALB/c mice and rabbit and the antibody titre was raised up to 128,000 after the 2(nd) booster dose. The developed polyclonal antibodies were highly specific and sensitive with a detection limit about 50 ng/ml for rBoNT/E LC and 2.5×10(3) MLD(50) of native crude BoNT/E at a dilution of 1:3000 of mouse (capturing) and rabbit (revealing) antibodies. Further, different liquid, semisolid and solid food matrices were tested, and rBoNT/E LC was detected in almost all food samples, but different levels of interference were detected in different food matrices. INTERPRETATION & CONCLUSIONS: There is no immune detection system available commercially in India to detect botulism. The developed system might be useful for the detection of botulinum toxin in food and clinical samples. Further work is in progress.
format Online
Article
Text
id pubmed-6118135
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-61181352018-09-07 Development of immunodetection system for botulinum neurotoxin serotype E Sarita, R. Ponmariappan, Sarkaraisamy Sharma, Arti Kamboj, Dev Vrat Jain, A. K. Indian J Med Res Original Article BACKGROUND & OBJECTIVES: Botulism, a potentially fatal paralytic illness, is caused by the botulinum neurotoxins (BoNTs) secreted by Clostridium botulinum. It is an obligate anaerobic, Gram-positive, spore-forming bacterium. BoNTs are classified into seven serotypes based on the serological properties. Among these seven serotypes, A, B, E and, rarely, F are responsible for human botulism. The present study was undertaken to develop an enzyme-linked immunosorbent assay (ELISA)-based detection system for the detection of BoNT/E. METHODS: The synthetic gene coding the light chain of BoNT serotype E (BoNT/E LC) was constructed using the polymerase chain reaction primer overlapping method, cloned into pQE30UA vector and then transformed into Escherichia coli M15 host cells. Recombinant protein expression was optimized using different concentrations of isopropyl-β-D-1-thiogalactopyranoside (IPTG), different temperature and the rBoNT/E LC protein was purified in native conditions using affinity column chromatography. The purified recombinant protein was checked by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and further confirmed by western blot and matrix-assisted laser desorption ionization-tandem time-of-flight (MALDI-TOF). Polyclonal antibodies were generated against rBoNT/E LC using Freund's adjuvant in BALB/c mice and rabbit. Sandwich ELISA was optimized for the detection of rBoNT/E LC and native crude BoNT/E, and food matrix interference was tested. The developed antibodies were further evaluated for their specificity/cross-reactivity with BoNT serotypes and other bacterial toxins. RESULTS: BoNT/E LC was successfully cloned, and the maximum expression was achieved in 16 h of post-induction using 0.5 mM IPTG concentration at 25°C. Polyclonal antibodies were generated in BALB/c mice and rabbit and the antibody titre was raised up to 128,000 after the 2(nd) booster dose. The developed polyclonal antibodies were highly specific and sensitive with a detection limit about 50 ng/ml for rBoNT/E LC and 2.5×10(3) MLD(50) of native crude BoNT/E at a dilution of 1:3000 of mouse (capturing) and rabbit (revealing) antibodies. Further, different liquid, semisolid and solid food matrices were tested, and rBoNT/E LC was detected in almost all food samples, but different levels of interference were detected in different food matrices. INTERPRETATION & CONCLUSIONS: There is no immune detection system available commercially in India to detect botulism. The developed system might be useful for the detection of botulinum toxin in food and clinical samples. Further work is in progress. Medknow Publications & Media Pvt Ltd 2018-06 /pmc/articles/PMC6118135/ /pubmed/30168493 http://dx.doi.org/10.4103/ijmr.IJMR_1375_16 Text en Copyright: © 2018 Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Sarita, R.
Ponmariappan, Sarkaraisamy
Sharma, Arti
Kamboj, Dev Vrat
Jain, A. K.
Development of immunodetection system for botulinum neurotoxin serotype E
title Development of immunodetection system for botulinum neurotoxin serotype E
title_full Development of immunodetection system for botulinum neurotoxin serotype E
title_fullStr Development of immunodetection system for botulinum neurotoxin serotype E
title_full_unstemmed Development of immunodetection system for botulinum neurotoxin serotype E
title_short Development of immunodetection system for botulinum neurotoxin serotype E
title_sort development of immunodetection system for botulinum neurotoxin serotype e
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118135/
https://www.ncbi.nlm.nih.gov/pubmed/30168493
http://dx.doi.org/10.4103/ijmr.IJMR_1375_16
work_keys_str_mv AT saritar developmentofimmunodetectionsystemforbotulinumneurotoxinserotypee
AT ponmariappansarkaraisamy developmentofimmunodetectionsystemforbotulinumneurotoxinserotypee
AT sharmaarti developmentofimmunodetectionsystemforbotulinumneurotoxinserotypee
AT kambojdevvrat developmentofimmunodetectionsystemforbotulinumneurotoxinserotypee
AT jainak developmentofimmunodetectionsystemforbotulinumneurotoxinserotypee